drugset / Trial / NCT01509807
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504
Non-randomizedParallel-groupOpen-labelHealth-services research
Summary
This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Comparator | Morphine | Other / unclassified | — | Intravenous |
Indications
No indication recorded.